Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma

Edward Libby, MD, and Josh Epworth, ARNP, interpreted data on current and novel treatments, discussed how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluated the use of minimal residual disease testing in patients with multiple myeloma.

Detalles Bibliográficos
Autores principales: Libby, Edward, Epworth, Josh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857329/
https://www.ncbi.nlm.nih.gov/pubmed/33598330
http://dx.doi.org/10.6004/jadpro.2020.11.3.17
Descripción
Sumario:Edward Libby, MD, and Josh Epworth, ARNP, interpreted data on current and novel treatments, discussed how to select initial therapy based on patient risk and in alignment with guidelines and best practices, and evaluated the use of minimal residual disease testing in patients with multiple myeloma.

Ejemplares similares